Atropine Sulfate Injection · #1 of 35 active shortages by FDA posting duration
FDA lists Atropine Sulfate Injection as Active Shortage (Accord Healthcare Inc.).
Availability on file: Unavailable
Atropine Sulfate Injection: Active Shortage
Unavailable 18 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Atropine Sulfate Injection
- Manufacturer
- Accord Healthcare Inc.
- Dosage Form
- Injection
- Presentation
- Atropine Sulfate, Injection, 1 mg/1 mL (NDC 16729-526-08)
- Package NDC
- 16729-526-08
Status & Timeline
- Status
- Active Shortage
- Availability
- Unavailable
- First Reported
- Jan 1, 2012
- Last Updated
- Mar 17, 2026
- Therapeutic Category
- Anesthesia, Neurology, Pediatric
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Resupply: TBD
Full Drug Profile
atropine
Side effects, interactions, warnings & more
Nearby, Other Atropine Shortage Records
Atropine Sulfate Injection
Accord Healthcare Inc.
Injection
Atropine Sulfate Injection
American Regent, Inc.
Injection
Atropine Sulfate Injection
Accord Healthcare Inc.
Injection
Atropine Sulfate Injection
American Regent, Inc.
Injection
Atropine Sulfate Injection
Accord Healthcare Inc.
Injection
Atropine Sulfate Injection
Fresenius Kabi USA, LLC
Injection
FDA reason on file: Resupply: TBD. General shortage guidance lives on the tracker hub.